trending Market Intelligence /marketintelligence/en/news-insights/trending/tarhyzqjyef4haomp_vzmw2 content esgSubNav
In This List

Genus adds 2 nonexecutive directors to board

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Genus adds 2 nonexecutive directors to board

Genus plc appointed Lesley Knox and Ian Charles nonexecutive directors of the company, effective June 1 and July 1, respectively.

Knox is currently a nonexecutive director at Legal & General Group PLC and the Thomas Cook Group PLC. Ian Charles is co-founder and board director of Auspherix Ltd and co-founder of Arrow Therapeutics Ltd.

Basingstoke, U.K.-based Genus is an animal genetics company.